Cargando…
Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is a marker of Insulin Resistance (IR). Euglycemic-hyperinsulinemic clamp is the gold standard for measuring whole body IR (hepatic + peripheral IR). However, it is an invasive and expensive procedure. Ho...
Autores principales: | Qureshi, Kamran, Clements, Ronald H., Saeed, Fahad, Abrams, Gary A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925212/ https://www.ncbi.nlm.nih.gov/pubmed/20798875 http://dx.doi.org/10.1155/2010/741521 |
Ejemplares similares
-
Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease
por: Yun, Jung Won, et al.
Publicado: (2009) -
Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease
por: Hossain, Israt Ara, et al.
Publicado: (2016) -
Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects
por: Kim, Hwi Seung, et al.
Publicado: (2021) -
Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring
por: Oki, Yusuke, et al.
Publicado: (2018) -
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease
por: Harrison, Stephen A., et al.
Publicado: (2021)